12:00 AM
 | 
May 09, 2005
 |  BC Week In Review  |  Company News  |  Deals

Bone Care, Genzyme deal

GENZ will acquire BCII for about $33 per share, or $719 million, in cash. The deal price is a 38% premium to BCII's close of $23.83 on Tuesday, before the deal was...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >